Novel non-invasive method for urine mapping: Deep-learning-enabled SERS spectroscopy for the rapid differential detection of kidney allograft injury.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
PMID:

Abstract

The kidney allograft has been under continuous attack from diverse injuries since the very beginning of organ procurement, leading to a gradual decline in function, chronic fibrosis, and allograft loss. It is vital to routinely and precisely monitor the risk of injuries after renal transplantation, which is difficult to achieve because the traditional laboratory tests lack sensitivity and specificity, and graft biopsies are invasive with the risk of many complications and time-consuming. Herein, a novel method for the diagnosis of graft injury is demonstrated, using deep learning-assisted surface-enhanced Raman spectroscopy (SERS) of the urine analysis. Specifically, we developed a hybrid SERS substrate composed of gold and silver with high sensitivity to the urine composition under test, eliminating the need for labels, which makes measurements easy to perform and meanwhile results in extremely abundant and complex Raman vibrational bands. Deep learning algorithms were then developed to improve the interpretation of the SERS spectral fingerprints. The deep learning model was trained with SERS signals of urine samples of recipients with different injury types including delayed graft function (DGF), calcineurin-inhibitor toxicity (CNIT), T cell-mediated rejection (TCMR), antibody-mediated rejection (AMR), and BK virus nephropathy (BKVN), which explored the features of these types and achieved the injury differentiation with an overall accuracy of 93.03%. The results highlight the potential of combining label-free SERS spectroscopy with deep learning as a method for liquid biopsy of kidney allograft injuries, which can provide great potential to diagnose and evaluate allograft injuries, and thus extend the life of kidney allografts.

Authors

  • Xi Chen
    Department of Critical care medicine, Shenzhen Hospital, Southern Medical University, Guangdong, Shenzhen, China.
  • Kailin Lin
    Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Kewen Chen
    Department of Organ Transplantation, Shanghai Changhai Hospital, Navy Medical University, Shanghai 200433, China.
  • Luyao Wang
    Department of Genetics, School of Life Sciences, Bengbu Medical University, Bengbu, China.
  • Hongyi Liu
    Department of General Surgery II, the First Medical Center of Chinese PLA General Hospital, Fuxing Road, Haidian District, Beijing, China.
  • Pei Ma
    Key Laboratory of Optical Technology and Instrument for Medicine, Ministry of Education, University of Shanghai for Science and Technology, Shanghai 200093, China.
  • Li Zeng
    Wenzhou Medical University, Wenzhou, China.
  • Xuedian Zhang
    School of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
  • Mingxing Sui
    Department of Organ Transplantation, Shanghai Changhai Hospital, Navy Medical University, Shanghai 200433, China. Electronic address: mingxingsui@163.com.
  • Hui Chen
    Xiangyang Central HospitalAffiliated Hospital of Hubei University of Arts and Science Xiangyang 441000 China.